Immune Therapy’s Hidden Cost: Nearly Three in Ten Lung Cancer Patients Face Severe Financial Toxicity
A latent profile analysis of 331 lung cancer patients receiving immunotherapy identified three distinct financial toxicity groups, with lower income, ...
